| Literature DB >> 35164048 |
Kobra Khodarahmian1, Alireza Ghiasvand1.
Abstract
Due to the growing prevalence of incurable diseases, such as cancer, worldwide, nowadays, the development of smart drug delivery systems is an inevitable necessity. Chemotaxis-driven movement of ionic liquid microdroplets containing therapeutic compounds is a well-known example of a smart drug delivery system. This review aims to classify, summarize, and compare ionic liquid-based chemotaxis systems in an easily understandable article. Chemotaxis is the basis of the movement of cells and microorganisms in biological environments, which is the cause of many vital biochemical and biological processes. This review attempts to summarize the available literature on single-component biomimetic and self-propelling microdroplet systems based on ionic liquids, which exhibit chemotaxis and spontaneously move in a determined direction by an external gradient, particularly a chemical change. It also aims to review artificial ionic liquid-based chemotaxis systems that can be used as drug carriers for medical purposes. The various ionic liquids used for this purpose are discussed, and different forms of chemical gradients and mechanisms that cause movement in microfluidic channels will be reviewed.Entities:
Keywords: chemotaxis; drug delivery; ionic liquid
Mesh:
Substances:
Year: 2022 PMID: 35164048 PMCID: PMC8839142 DOI: 10.3390/molecules27030786
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The most used cations and anions for the synthesized of ILs. Reproduced from [25] with permission.
Full names and abbreviations of some commonly used ILs. Reproduced from [26] with permission.
| Name | Abbreviation |
|---|---|
| triisobutyl (methyl) phosphonium tosylate | [P1,4,4,4][Tos] |
| tetrabutylphosphonium dicyanamide | [P4,4,4,4][DCA] |
| trihexyltetradecyl phosphonium dicyanamide | [P6,6,6,14][DCA] |
| trihexyltetradecyl phosphonium bis (trifluoromethanesulfonyl) imide | [P6,6,6,14][Ntf2] |
| trihexyltetradecyl phosphonium dodecylbenzenesulfonate | [P6,6,6,14][DBSA] |
| trihexyltetradecyl phosphonium chloride | [P6,6,6,14][Cl] |
| 1-methyl-3-octylimidazolium tetrafluoroborate | [OMIM][BF4] |
| 1-ethyl-3-methyliidazolium methyl sulphate | [EMIM][MeSO4] |
| 1-ethyl-3-methyl imidazolium ethyl sulfate | [EMIM][EtSO4] |
| 1-butyl-3-methylimidazolium hydrogen sulphate | [BMIM][HSO4] |
| 1-ethyl-3-methyl imidazolium tetrafluoroborate | [EMIM][BF4] |
| 1-ethyl-3-methylimidazolium dicyanamide | [EMIM][DCA] |
| 1-butyl-3-methylimidazolium tetrafluoroborate | [BMIM][BF4] |
| 1-butyl-3-methylimidazolium hexafluorophosphate | [BMIM][PF6] |
| 1-butyl-3-methylimidazolium dodecanesulfonate | [BMIM][DoS] |
| 1-butyl-3-methylimidazolium bis(trifluoromethanesulfonyl)imide | [BMIM][NTf2] |
| 1-hexyl-3-methylimidazolium bis (trifluoromethanesulfonyl) imide | [HMIM][NTf2] |
| 1-buty1-butyl-4-methylpyridinum tetrafluoroborate | [BMPy][BF4] |
The use of ILs as green solvents, microreactors, and extractants for synthesis and separation purposes.
| Application | IL Name | IL Class | Ref. |
|---|---|---|---|
| Separation and extraction of heavy metal ions including Hg2+ and Cd2+ from aqueous solution into [C4mim][PF6] | 1-butyl-3 methylimidazolium hexafluorophosphate, [C4mim][PF6] | RTIL | [ |
| Extraction and preconcentration of Cd2+ and Hg2+ from aqueous samples into a mixture of different TSILs and a RTIL, [C4mim][PF6] | Combinations of derivatized imidazolium cations with urea, thiourea, and thioether, mixed with 1-butyl-3 methylimidazolium hexafluorophosphate, [C4mim][PF6] | TSILs and RTILs | [ |
| Synthesis of organic compounds by using ILs as electronic microreactor | 1-butyl-3-methylimidazolium tetrafluoroborate, [bmim][BF4], and 1-butyl-3-methylimidazolium hexafluorophosphate, [bmim][PF6] | RTIL and RTIL | [ |
| Dissolution of a softwood lignin in different ionic liquids as aprotic green solvents | 1-hexyl-3-methylimidazolium trifluoromethanesulfonate, [hmim][CF3SO3], 1,3-dimethylimidazolium methylsulfate, [mmim][MeSO4], and 1-butyl-3-methylimidazolium methylsulfate [bmim][MeSO4] | TSIL, RTIL, and RTIL | [ |
| Removal of phenolic compounds such as pentachlorophenol by use of magnetic room-temperature ionic liquid (MRTIL) | trihexyltetradecyl phosphonium etrachloroferrate (III), [3C6PC14][FeCl4] | MRTIL | [ |
| Extraction of three alkaloids from lotus leaf | 1-hexyl-3-methylimidazolium bromide, ([C(6)MIM]Br) | TSIL | [ |
| Extraction and determination of flavonoids from Bauhinia championii | 1-butyl-3-methylimidazolium bromide, ([bmim]Br) | TSIL | [ |
| Effective extraction of rutin from Chinese medicinal plants | 1-butyl-3-methylimidazolium bromide, ([bmim]Br) | TSIL | [ |
| Separation of tannins from plant materials | TSIL | [ | |
| Extraction and isolation of shikimic acid from Ginkgo biloba leaves | 1-butyl-3-methylimidazolium chloride, ([bmim]Cl) | TSIL | [ |
| Extraction of Shikonin and | 1-hexyl-3-methylimidazolium tetrafluoroborate, [C(6)MIM][BF4] | RTIL | [ |
Figure 2Formation of marble-like liquid microdroplets using (a) Fe2O3 and (b) Fe3O4 nanoparticles after suspension in a liquid. The marble can be opened and exposed to it water content (dark blue circle) when the magnetic nanoparticles are pulled by the magnetic field. (c) Mechanism of preparation and motion of reduced graphene-oxide motor. Reproduced from [14] with permission.
Figure 3(a) Depiction of a SAW-propagating liquid on a piezoelectric substrate and (b) schematic illustration of the interaction between a SAW (which is propagating from left to right, and at x = 0, hits the liquid) and a liquid microdroplet on the surface of the piezoelectric substrate. A longitudinal sound wave is irradiated into the fluid under a refraction angular of Θ. Reproduced from [13] with permission.
Figure 4(a) Monolayer formed by azobenzene-containing CRA-CM amphiphiles and (b) sequence of light-driven motion of an olive oil droplet on the CRA-CM photoresponsive surface. The olive oil droplet on a cis-rich surface moves in a direction of a higher-energy surface by asymmetric irradiation with 436 nm light perpendicular to the surface. The contact angles were changed from 18° (1) to 25° (3). The droplet movement route was controllable by varying the photoirradiation direction. Reproduced from [55] with permission.
Figure 5Drug delivery by an artificial tactic motion: (a) Artificial cell, a microdroplet stabilized by a bilayer of a fatty acid or phospholipid molecules, containing a drug; (b) controlled tactic motion by the Marangoni effect to the target; and (c) drug delivery from the artificial cell to the target through the membrane of the target cell. Reproduced from [63] with permission.
Figure 6Maze solving by chemotactic droplets (HDA in DCM) in a pH gradient in a maze (the droplets move toward regions of low pH through the shortest possible path). (a) The HDA/DCM droplet solves the maze without any deviation, and (b) the droplet drifts in two locations but eventually corrects itself to find the shortest path leading to the maze’s exit. Reproduced from [20] with permission.
Figure 7Non-uniform distribution of HDA at the liquid–air interface, resulting in variations of surface tension over the droplet surface. Due to the presence of more HDA in the direction of the acid source (low pH), the forces and flows are asymmetric. Reproduced from [20] with permission.
Figure 8Schematic representation of the stages of events resulting in the appearance of surface motion and flows: (a) A symmetrical oil microdroplet immersed in the aqueous phase; (b) the oil microdroplet covered with surfactant; and (c) internal discrete structures within the oil microdroplets cause oscillatory movements and expose the oil to the alkaline external solution (possible sites of hydrolysis are shown by red circles). After the formation of the vortices, the convection flow begin (black arrows inside the oil phase), the surfactant moves to the prior pole, and the hydrolysis of the oil microdroplet is localized (red circle). The blue lines indicate the exit of the surfactant from the interface, which causes the microdroplet to move. Reproduced from [59] with permission.
Figure 9Schematic illustration of the hydrolytic reaction in an oil self-propelled droplet. Chemical fuel (surfactant, 1) produces aniline lipophilic derivative (2) and benzaldehyde hydrophilic derivative (3) in the presence of the catalyst (4). Reproduced from [60] with permission.
Figure 10Motion of an IL droplet in an open channel fluidic system: (a) Creating a concentration gradient of Cl− by adding hydrochloric acid (10−2 M) in the fluidic channel initially filled with a NaOH solution (10−2 M); (b) an IL droplet is placed at the beginning of the channel that begins to release the surfactant into the solution and creates a surface tension gradient around the droplet; (c) the droplet then moves towards regions with the highest surface tension; and (d) the droplet arrives at the favorite destination. Reproduced from [65] with permission.
Figure 11Relative solubility of the surfactant droplet, [P6,6,6,14][Cl], in lower (at the cathode, top) and higher (at the anode, bottom) concentrations of Cl−. Reproduced from [66] with permission.
Summary of the drug delivery reports based on self-propelled ILs’ droplets.
| Drug Delivery Application | Chemotactic System (IL Name) | Ref. |
|---|---|---|
| Transdermal delivery of Acyclovir (to treat infections caused by certain types of viruses such as cold sores around the mouth) | dimethylimidazolium dimethylphosphate [C1mim][(MeO)2PO2] | [ |
| Targeted delivery of Epirubicin (anticancer drug) | trihexyltetradecyl phosphonium chloride ([P6,6,6,14][Cl]) | [ |
| Encapsulating of glucose oxidase alone or in combination with catalase into biocompatible nanoscopic asymmetric polymer vesicles (polymersomes), applications in blood–brain barrier crossing | asymmetric polymersomes: poly [(2-methacryloyl) ethyl phosphorylcholine]–poly[2-(diisopropylamino) ethyl methacrylate] (PMPC-PDPA) and poly[oligo (ethylene glycol) methyl methacrylate] (POEGMA-PDPA) | [ |
| Delivery of Piroxicam (a nonsteroidal anti-inflammatory drug), which is sparingly soluble in water | 1-hexyl-3-methylimidazolium chloride [Hmim][Cl] and 1-butyl-3-methylimidazolium hexafluorophosphate [Bmim][PF6] | [ |
| Development of a highly effective oral insulin formulation and delivery | choline and geranate (CAGE) ionic liquid | [ |
| Transport live cells protected in alginate capsules as a protective unit along chemical gradients | 1-decanol chemotactic droplets in an aqueous medium containing decanoate at high pH by chemical gradient in the external aqueous environment | [ |
| Delivery of biologically active anionic pharmaceuticals for anti-inflammatory and anti-coagulant therapy | salicylate decorating poly (2-(trimethylammonium) ethyl methacrylate based on a pharmaceutical ionic liquid | [ |